---
layout: talk_reveal4
title: Continuing SARS-CoV-2 evolution and diversification post-Omicron
venue: Institute for Advanced Studies
event: Science for Resilience - Learnings from the Pandemic
author: Trevor Bedford
widescreen: true
---

<!-- 18 min talk + 5 min Q&A -->

<!--
Outline:
 - SARS-CoV-2 evolution over the course of the pandemic
 - Omicron emergence and spread
 - Emerging variants
 - Expectations for endemicity
-->

<!-- Color ramp: [#5097BA", "#60AA9E", "#75B681", "#8EBC66", "#AABD52", "#C4B945", "#D9AD3D", "#E59637", "#E67030", "#DF4327"] -->

<section data-transition="fade" data-background="#000">
	<h2 class="title">{{ page.title }}</h2>
	<br>&nbsp;<br>
	<p class="title">
	Trevor Bedford (@trvrb)
	<br>
	Fred Hutchinson Cancer Center / Howard Hughes Medical Institute
	<br>
	{{ page.date | date: "%-d %b %Y" }}
	<br>
	{{ page.event }}
	<br>
	{{ page.venue }}
	<br>&nbsp;<br>
	Slides at: bedford.io/talks	
</section>


<!-- Introduction -->

<section data-transition-speed="slow" data-background="/images/talks/ncov_tree_unrooted_2021_09_11.png">
</section>

<section class="left-align">
	<h3>1. SARS-CoV-2 evolution over the course of the pandemic</h3>
	<h3>2. Omicron emergence and spread</h3>
	<h3>3. Emerging variants</h3>
	<h3>4. Expectations for endemicity</h3>
</section>

<!-- SARS-CoV-2 evolution over the course of the pandemic -->

<section data-transition="fade" data-background="#5097BA">
	<h1 class="title">SARS-CoV-2 evolution over the course of the pandemic</h1>
</section>

<section>
	<h3>Genetic relationships of SARS-CoV-2</h3>
	<img class="stretch" data-src="/images/talks/ncov_variants_tree_unrooted_2022_05_22.png">
	<div class="citation">
		<a href="https://nextstrain.org/ncov/gisaid/global/all-time?l=unrooted&m=div">nextstrain.org</a>
	</div>
</section>

<section>
	<h3>Global SARS-CoV-2 evolution over the course of the pandemic</h3>
	<img class="stretch" data-src="/images/talks/ncov_tree_freq_2022_05_17.png">
	<div class="citation">
		<a href="https://nextstrain.org/ncov/gisaid/global/all-time">nextstrain.org</a>
	</div>
</section>

<section>
	<h3>Rapid accumulation of spike mutations driving displacement</h3>
	<img class="stretch" data-src="/images/talks/ncov_tree_scatter_s1_mutations_2022_05_17.png">
	<div class="citation">
		<a href="https://nextstrain.org/ncov/gisaid/global/all-time?branchLabel=none&l=scatter&m=div&scatterX=num_date&scatterY=S1_mutations">nextstrain.org</a>
	</div>
</section>

<section>
	<h3>S1 evolved at a rate of 11 amino acid changes per year in 2021</h3>
 	<img class="stretch" data-src="/images/talks/ncov_mutation_rate_spike_clock_2022_05_17.png">
</section>

<section>
	<h3>S1 evolution remarkably fast relative to seasonal influenza</h3>
 	<img class="stretch" data-src="/images/talks/ncov_mutation_rate_compared_to_flu_2022_05_17.png">
</section>

<!-- Omicron emergence and spread -->

<section data-transition="fade" data-background="#60AA9E">
	<h1 class="title">Omicron emergence and spread</h1>
</section>

<section>
	<h3>Omicron viruses possess huge excess of mutations in S1</h3>
	<img class="stretch" data-src="/images/talks/ncov_omicron_s1_mutations_2022_02_20.png">
	<div class="citation">
		<a href="https://nextstrain.org/ncov/gisaid/global?l=scatter&scatterY=S1_mutations">nextstrain.org</a>
	</div>
</section>

<section>
	<h3>Omicron spike mutations substantially drop VE against infection</h3>
 	<img class="stretch" data-src="/images/talks/ncov_omicron_ve_ukhsa_2022_01_14.png">
	<div class="citation">
 		<a href="https://www.gov.uk/government/publications/investigation-of-sars-cov-2-variants-technical-briefings">UKHSA. 2022. Technical Report.</a>
 	</div>
</section>

<section>
	<h3>Significant immune escape drove large-scale epidemics</h3>
	<img class="stretch" data-src="/images/talks/ncov_omicron_rt_log_cases_2022_03_13.png">
	<div class="citation">
		<a href="/papers/figgins-rt-from-frequency-dynamics/">Figgins and Bedford. 2021. medRxiv.</a>
	</div>
</section>

<section>
	<h3>Starting Rt approached that of the initial wave in spring 2020</h3>
	<img class="stretch" data-src="/images/talks/ncov_omicron_rt_2022_03_13.png">
	<div class="citation">
		<a href="/papers/figgins-rt-from-frequency-dynamics/">Figgins and Bedford. 2021. medRxiv.</a>
	</div>
</section>

<section class="left-align">
	<h3>Omicron attack rate</h3>
	<p>
	<ol>
		<li>
			We estimate US has seen 9.8% of the population as confirmed cases of Omicron through Mar 3, with the
			large majority accumulating after Dec 15
		</li>
		<li>
			Assuming a case detection rate of 1 in 5 infections, we estimate almost 50% of the US infected with Omicron, most in the span of ~10 weeks
		</li>
	</ol>
	</p>
</section>

<section>
	<h3>Similar epidemics across US states with downturn driven by immunity</h3>
	<img class="stretch" data-src="/images/talks/ncov_omicron_rt_us_cases_vs_rt_2022_03_13.png">
	<div class="citation">
		<a href="/papers/figgins-rt-from-frequency-dynamics/">Figgins and Bedford. 2021. medRxiv.</a>
	</div>
</section>

<!-- Emerging variants -->

<section data-transition="fade" data-background="#75B681">
	<h1 class="title">Emerging variants</h1>
</section>

<section>
	<h3>Initial variants characterized by repeated evolution at spike 484K and 501Y</h3>
	<img class="stretch" data-src="/images/talks/ncov_variants_484K_501Y_2021_05_07.png">
	<div class="citation">
		<a href="https://nextstrain.org/ncov/global?c=gt-S_484,501">nextstrain.org</a>
	</div>
</section>

<section>
	<h3>We're now seeing repeated evolution at spike 452</h3>
	<img class="stretch" data-src="/images/talks/ncov_variants_452R_2022_05_17.png">
	<div class="citation">
		<a href="https://nextstrain.org/ncov/gisaid/global/6m?c=gt-S_452">nextstrain.org</a>
	</div>
</section>

<section>
	<h3>This pattern is familiar from seasonal influenza</h3>
	<img class="stretch" data-src="/images/talks/nextflu_h3n2_tree_186D_2022_05_17.png">
	<div class="citation">
		<a href="https://nextstrain.org/flu/seasonal/h3n2/ha/3y?c=gt-HA1_186">nextstrain.org</a>
	</div>
</section>

<section>
	<h3>BA.4 and BA.5 emerging from South Africa with spike mutations 452R and 486V</h3>
	<img class="stretch" data-src="/images/talks/ncov_variants_ba.4_ba.5_tree_map.png">
	<div class="citation">
		<a href="https://nextstrain.org/ncov/gisaid/africa/6m">nextstrain.org</a>
	</div>
</section>

<section>
	<h3>BA.2.12.1 emerging from Northeastern US bearing spike mutation 452Q</h3>
	<img class="stretch" data-src="/images/talks/ncov_variants_ba.2.12.1_tree_map.png">
	<div class="citation">
		<a href="https://nextstrain.org/ncov/gisaid/north-america/6m">nextstrain.org</a>
	</div>
</section>

<section>
 <h3>Variant-specific epidemics shown by partitioning case counts with variant frequency</h3>
 <img class="stretch" data-src="/images/talks/ncov_variants_rt_countries_log_cases_2022_05_22.png">
 <div class="citation">
	 <a href="/papers/figgins-rt-from-frequency-dynamics/">Figgins and Bedford. 2021. medRxiv.</a>
 </div>
</section>

<section>
 <h3>BA.4, BA.5, BA.2.12.1 driving cases across countries</h3>
 <img class="stretch" data-src="/images/talks/ncov_variants_rt_countries_2022_05_22.png">
 <div class="citation">
	 <a href="/papers/figgins-rt-from-frequency-dynamics/">Figgins and Bedford. 2021. medRxiv.</a>
 </div>
</section>

<section>
 <h3>Rt for BA.2.12.1 greater than BA.2 and Rt for BA.4/5 greater still</h3>
 <img class="stretch" data-src="/images/talks/ncov_variants_rt_us_log_cases_2022_05_22.png">
 <div class="citation">
	 <a href="/papers/figgins-rt-from-frequency-dynamics/">Figgins and Bedford. 2021. medRxiv.</a>
 </div>
</section>

<!-- <section>
 <h3>Relative fitness of BA.4, BA.5 and BA.2.12.1 visible in the US</h3>
 <img class="stretch" data-src="/images/talks/ncov_variants_rt_us_frequencies_logit_2022_05_17.png">
 <div class="citation">
	 <a href="/papers/figgins-rt-from-frequency-dynamics/">Figgins and Bedford. 2021. medRxiv.</a>
 </div>
</section> -->

<section>
 <h3>BA.4 and BA.5 driving substantial epidemics in South Africa</h3>
 <img class="stretch" data-src="/images/talks/ncov_variants_rt_south_africa_cases_2022_05_17.png">
 <div class="citation">
	 <a href="/papers/figgins-rt-from-frequency-dynamics/">Figgins and Bedford. 2021. medRxiv.</a>
 </div>
</section>

<!-- Expectations for endemicity -->

<section data-transition="fade" data-background="#8EBC66">
	<h1 class="title">Expectations for endemicity</h1>
</section>

<!-- <section>
	<h3>SARS-CoV-2 will continue to evolve to escape population immunity, though with multiple potential avenues</h3>
	<img class="stretch" data-src="/images/talks/ncov_omicron_tree_2022_01_18_scenarios.png">
</section>

<section>
	<h3>With 1 observation in 2.52 years of virus evolution, it's currently unclear how common Omicron-like events will be</h3>
	<img class="stretch" data-src="/images/talks/ncov_omicron_wait_time_distribution_2022_05_22.png">
</section>

<section>
	<h3>This rate distribution gives a naive prediction of Omicron-like emergence events occurring in the next 12 months</h3>
	<img class="stretch" data-src="/images/talks/ncov_omicron_prediction_distribution_2022_05_22.png">
</section>

<section class="left-align">
	<h3>Likely scenarios over the next 12 months</h3>
	<p>
	<ol>
		<li>
			Evolution within Omicron to further increase intrinsic transmission and to escape from Omicron-derived immunity. This scenario sees lower attack rates with 2022-2023 epidemic driven by drift + waning + seasonality.
		</li>
		<li>
			Another Omicron-like emergence event in which a chronic infection initiated in ~2021 incubates a new wildly divergent virus. This scenario sees high attack rates with epidemic driven by variant emergence.
		</li>
	</ol>
	</p>
</section> -->

<section>
	<h3>Immunity and reduced intrinsic severity has dropped CFR</h3>
	<img class="stretch" data-src="/images/talks/ncov_severity_lagged_cfr_prediction_2022_05_17.png">
</section>

<section class="left-align">
	<h3>Broad expectations of endemicity based on comparison with flu</h3>
	<p>
	<ol>
		<li>
			<i>R</i><sub class="even-smaller">0</sub> of Delta/Omicron is perhaps ~6 compared to
			<i>R</i><sub class="even-smaller">0</sub> of flu of ~2. At same rates of evolution and waning
			expect more COVID circulation.
		</li>
		<li>
			Before Omicron rates of evolution in SARS-CoV-2 S1 had been roughly equal to H3N2 flu.
			Omicron equivalent to 5 years of H3N2 evolution.
		</li>
		<li>
			Infection fatality rate (IFR) of COVID is roughly comparable to flu once you have prior immunity.
		</li>
	</ol>
	</p>
	<p>
		1, 2 and 3 suggest a virus that circulates at higher levels than flu, but individual
		infections aren't much more severe in terms of mortality than H3N2 influenza.
	</p>
	<p>
		Seasonality suggests winter "COVID season", but Omicron-like events could overcome seasonality.
	</p>
</section>

<section class="left-align">
	<h3>Key parameters are seasonal attack rate and IFR</h3>
	<p>
	<ol>
		<li>
			Assume seasonal attack rate of 40%, with Omicron-like emergence driving 80% some years.
		</li>
		<li>
			Assume IFR of 0.05% (compared to early pandemic IFR of 0.5%), but new variant could push this higher.
		</li>
		<li>
			This would give somewhere around 20 per 100k population yearly deaths at endemicity, but potential for
			variant emergence to push this over 40 per 100k population.
		</li>
	</ol>
	</p>
</section>

<section>
	<h3>Acknowledgements</h3>

	<p class="even-smaller">
		<b>SARS-CoV-2 genomic epi</b>: Data producers from all over the world, GISAID and the Nextstrain team
	</p>

	<p class="tiny"><b>Bedford Lab</b>:
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/john-huddleston.jpg"> John Huddleston,</span> &hairsp;
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/james-hadfield.jpg"> James Hadfield,</span> &hairsp;
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/katie-kistler.jpg"> Katie Kistler,</span> &hairsp;
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/louise-moncla.jpg"> Louise Moncla,</span> &hairsp;
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/maya-lewinsohn.jpg"> Maya Lewinsohn,</span> &hairsp;
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/thomas-sibley.jpg"> Thomas Sibley,</span> &hairsp;
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/jover-lee.jpg"> Jover Lee,</span> &hairsp;
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/cassia-wagner.jpg"> Cassia Wagner,</span> &hairsp;
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/miguel-paredes.jpg"> Miguel Paredes,</span> &hairsp;
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/nicola-mueller.jpg"> Nicola MÃ¼ller,</span> &hairsp;
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/marlin-figgins.jpg"> Marlin Figgins,</span> &hairsp;
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/denisse-sequeira.jpg"> Denisse Sequeira,</span> &hairsp;
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/victor-lin.jpg"> Victor Lin,</span> &hairsp;
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/jennifer-chang.jpg"> Jennifer Chang</span>
	</p>

	<div class="pull-right" style="vertical-align: bottom; display: table-cell;">
		<img width="11%" data-src="/images/talks/logo_fred_hutch_vertical.png">
		&nbsp; &nbsp;
		<img width="8%" data-src="/images/talks/logo_pew.png">
		&nbsp; &nbsp;
		<img width="14%" data-src="/images/talks/logo_bmgf.png">
		&nbsp; &nbsp;
		<img width="12%" data-src="/images/talks/logo_gates_ventures.png">
		&nbsp; &nbsp;
		<img width="11%" data-src="/images/talks/logo_wellcome_trust.jpg">
		&nbsp; &nbsp;
		<img width="7%" data-src="/images/talks/logo_nih.jpg">
		&nbsp; &nbsp;
		<img width="8%" data-src="/images/talks/logo_hhmi.jpg">
	</div>
</section>
